These treatment pathways were developed by the type 2 diabetes subgroup of the PES Diabetes SIG, using evidence base when available in combination with expert clinical experience. They consist of 3 parts: 1. An algorithm to help triage patients with clinical features of type 2 diabetes when the type of diabetes has not yet been confirmed, 2. A clinical pathway for initial treatment of suspected type 2 diabetes until the diagnosis is confirmed, 3. Recommendations for weaning insulin in a patient with recently-diagnosed confirmed type 2 diabetes or after temporary metabolic decompensation.